CASCADE screening and registry of familial hypercholesterolemia in Iran: Rationale and design

Golnaz Vaseghi1, Sina Arabi2, Shaghayegh Haghjooy-Javanmard3

  • 1Assistant Professor, Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.

ARYA Atherosclerosis
|August 24, 2019
PubMed

Insights

Familial hypercholesterolemia (FH), a genetic disorder causing premature coronary artery disease (CAD), requires early detection. This study introduces a screening and registry program in Iran to identify and manage FH patients, optimizing their low-density lipoprotein cholesterol (LDL-C) levels.

Area of Science:

  • Cardiovascular Genetics
  • Public Health Screening
  • Genetic Epidemiology

Background:

  • Familial hypercholesterolemia (FH) is a prevalent genetic disorder linked to premature coronary artery disease (CAD).
  • Early diagnosis and treatment of FH are crucial to mitigate the risk of premature CAD events.
  • Current diagnostic methods include clinical features, family history, and LDL-C levels, with DNA-based detection offering high accuracy.

Purpose of the Study:

  • To establish a screening and registry program for Familial hypercholesterolemia (FH) in Iran.
  • To identify individuals with FH and facilitate early intervention and management.
  • To optimize low-density lipoprotein cholesterol (LDL-C) levels in affected families.

Main Methods:

  • Screening the general population through laboratories based on elevated LDL-C levels (≥190 mg/dl or ≥150 mg/dl if treated).
  • Implementing a hospital-based approach to screen hospitalized patients with premature CAD events.
  • Utilizing the CASCADE method for screening and patient registration.

Main Results:

  • The study initiated screening and registration of FH patients in Iran.
  • Families of identified FH patients were targeted for screening to ensure comprehensive care.
  • The aim was to provide standard care and therapy to optimize LDL-C levels.

Conclusions:

  • This article details the rationale and design of the FH screening and registry in Iran.
  • The program aims to address the lack of prior FH screening in the country.
  • Early detection and management are emphasized to reduce the burden of premature CAD.
Abstract

Related Concept Videos

Protein Families02:47

Protein Families

Protein families are groups of homologous proteins; that is, they have similarities in amino acid sequences and three-dimensional structures. Protein families usually occur because of gene duplication, where an additional copy of a gene is inserted into the genome of an organism.   Mutations that change the amino acids but still allow the protein to be properly synthesized, will lead to new protein family members.   If these new proteins contain similar amino acids in key...
16.7K
Protein Families02:47

Protein Families

4.3K
Gene Families01:57

Gene Families

Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
9.8K
Gene Families01:57

Gene Families

3.5K
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
53.3K